Aygul Valiullina
Overview
Explore the profile of Aygul Valiullina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chasov V, Gilyazova E, Ganeeva I, Zmievskaya E, Davletshin D, Valiullina A, et al.
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766360
Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint inflammation, progressive tissue damage and significant disability, severely impacting patients' quality of life. While the exact mechanisms underlying...
2.
Khaliulin M, Valiullina A, Petukhov A, Yuan Y, Spada S, Bulatov E
Cancer Immunol Immunother
. 2024 Nov;
74(1):3.
PMID: 39487875
The use of chimeric antigen receptor (CAR)-T cells has enhanced the range of available therapeutic modalities in the context of cancer treatment. CAR-T cells have demonstrated considerable efficacy in the...
3.
Chasov V, Ganeeva I, Zmievskaya E, Davletshin D, Gilyazova E, Valiullina A, et al.
Cells
. 2024 Aug;
13(15.
PMID: 39120313
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints. Although much remains unknown about the pathogenesis of RA, there is evidence that impaired immune tolerance...
4.
Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Filimonova M, et al.
J Biomed Res
. 2024 Jun;
:1-16.
PMID: 38828853
Systemic lupus erythematosus (SLE) is characterized by a systemic dysfunction of the innate and adaptive immune systems, leading to an attack on healthy tissues of the body. During the development...
5.
Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Khaliulin M, et al.
Antibodies (Basel)
. 2024 Feb;
13(1).
PMID: 38390871
Systemic autoimmune diseases (SAIDs), such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and rheumatoid arthritis (RA), are fully related to the unregulated innate and adaptive immune systems involved in...
6.
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
Ganeeva I, Zmievskaya E, Valiullina A, Kudriaeva A, Miftakhova R, Rybalov A, et al.
Bioengineering (Basel)
. 2022 Dec;
9(12).
PMID: 36551014
Harnessing the human immune system as a foundation for therapeutic technologies capable of recognizing and killing tumor cells has been the central objective of anti-cancer immunotherapy. In recent years, there...
7.
Titov A, Kaminskiy Y, Ganeeva I, Zmievskaya E, Valiullina A, Rakhmatullina A, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205827
Immunotherapy using chimeric antigen receptor (CAR) T cells is a promising option for cancer treatment. However, T cells and CAR-T cells frequently become dysfunctional in cancer, where numerous evasion mechanisms...
8.
Titov A, Zmievskaya E, Ganeeva I, Valiullina A, Petukhov A, Rakhmatullina A, et al.
Cancers (Basel)
. 2021 Mar;
13(4).
PMID: 33670139
Adoptive cell immunotherapy (ACT) is a vibrant field of cancer treatment that began progressive development in the 1980s. One of the most prominent and promising examples is chimeric antigen receptor...
9.
Zmievskaya E, Valiullina A, Ganeeva I, Petukhov A, Rizvanov A, Bulatov E
Biomedicines
. 2021 Jan;
9(1).
PMID: 33435454
Adoptive cell transfer (ACT) has long been at the forefront of the battle with cancer that began last century with the therapeutic application of tumor-infiltrating lymphocytes (TILs) against melanoma. The...
10.
Chasov V, Mirgayazova R, Zmievskaya E, Khadiullina R, Valiullina A, Stephenson Clarke J, et al.
Front Oncol
. 2020 Sep;
10:1460.
PMID: 32974171
The transcription factor p53 is a key tumor suppressor that is inactivated in almost all cancers due to either point mutations in the gene or overexpression of its negative regulators....